Research and Clinical Trials Our fact-checking process starts with a thorough review of all sources to ensure they are of high quality. We then compare the facts with original medical.
Austin, Texas, July 22, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and world leader in cell-free DNA testing, today announced the publication of a new peer-reviewed study validating.
Read article AstraZeneca's Imfinzi (durvalumab) has been approved in China for the first-line treatment of adult patients with extensive small cell lung cancer (ES-SCLC), in combination with standard platinum chemotherapy.
January 18, 2019 5 minutes reading ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted Enter your email address to receive an email when new articles.
A mother found out she had cancer three months after her GP left a voicemail on her broken cell phone and asked her to come in. Despite fears that Rachel.
DUBLIN--(BUSINESS WIRE)--The “Extended Stage Small Cell Lung Cancer (ESCLC) – Pipeline Insight, 2021” drug pipelines has been added to: ResearchAndMarkets.com's to offer. This report "Extensive-Stage Small Cell Lung Cancer (ESCLC).